Digital validation software company Kneat.com, Inc. is set to go private after entering into a definitive arrangement agreement with an affiliate of private equity giant Thoma Bravo, L.P. in an all-cash transaction valued at approximately $650 million. The deal will see Thoma Bravo acquire all issued and outstanding common shares of Kneat at $6.50 per share, which is a 40 percent premium to the company's unaffected share price, in one of the more notable Canadian software take-privates of 2026.
Kneat provides digital validation and quality process automation software through its Kneat Gx platform, serving pharmaceutical, biotechnology, and medical device manufacturers and other companies in highly regulated industries. Its platform digitizes validation and compliance workflows, maintaining the data integrity and traceability requirements central to life sciences regulation.
The transaction lands in the middle of a sustained downturn in subscription software valuations, which by some measures sit at their lowest levels in at least 13 years. The slump began after the pandemic-era tech bubble burst in late 2021, deepened as interest rates climbed sharply, and has since been compounded by investor concerns over the competitive threat posed by generative artificial intelligence companies.
Recent Articles
Against that backdrop, the population of publicly listed software companies on the TSX has been steadily thinning through a wave of take-private transactions that Thoma Bravo helped kick off in 2023 with its $1.8-billion acquisition of Magnet Forensics Inc., just two years after Magnet's initial public offering. Many of the Canadian technology companies that went public on the TSX during the pandemic-fueled IPO boom of 2020 and 2021, Magnet included, have since gone private through buyouts or delistings. Other TSX-listed names, including Dayforce Inc. (acquired by Thoma Bravo last year), Absolute Software Corp., Information Services Corp., and Blackline Safety Corp., have either been privatized or agreed to deals. Thoma Bravo has also been a frequent buyer of privately held Canadian tech companies, including Trader Corp., Cority Software Inc., and Circle Cardiovascular Imaging Inc. in recent years.
“In today’s increasingly complex regulatory environment, more customers are looking to Kneat to provide them with greater control, efficiency, and real-time visibility across mission-critical compliance workflows,” Thoma Bravo partner Adam Solomon said in a press release. “We are confident we can apply our operational expertise and deep experience working with market-leading software companies to accelerate Kneat’s growth.”
“We are thrilled to partner with Thoma Bravo, who we are confident will help us accelerate our mission and our position as the leader in digital validation and quality process automation for life sciences at an exciting time for the industry,” said Kneat CEO and co-founder Eddie Ryan. “As we begin to leverage our critical position in validation to enable customers to expand their use of our platform to adjacent areas, having the sector expertise, strategic alignment, and resources of Thoma Bravo behind us will be a powerful catalyst.”
On the legal side, Goodmans LLP is serving as Canadian legal counsel and Kirkland & Ellis LLP as U.S. legal counsel to Thoma Bravo. Fogler, Rubinoff LLP is acting as legal counsel to Kneat, and Dentons Canada LLP is advising the special committee of the Kneat board.
CIBC Capital Markets acted as exclusive financial advisor to the special committee, with ATB Cormark Capital Markets providing an independent fairness opinion. Scotiabank served as financial advisor to Thoma Bravo.
The transaction will be implemented by way of a court-approved plan of arrangement under the Canada Business Corporations Act. Shareholder approval requires at least two-thirds of votes cast at a special meeting expected in early August 2026.
Closing is expected in the third quarter of 2026, subject to court and regulatory approvals.
For comprehensive access to our database of all published deal information, subscribe to the CL+ platform.